Literature DB >> 9354527

Coronary artery bypass grafting in immune thrombocytopenic purpura.

T C Mathew1, R Vasudevan, L Leb, S M Pezzella, A T Pezzella.   

Abstract

BACKGROUND: Reports of patients with idiopathic thrombocytopenic purpura undergoing cardiac operations are scarce and no recommendations exist regarding their management. We report 3 patients with idiopathic thrombocytopenic purpura and severe coronary artery disease who underwent uncomplicated coronary bypass grafting.
METHODS: The case history of each patient with idiopathic thrombocytopenic purpura who underwent coronary artery bypass grafting and the literature were reviewed.
RESULTS: All 3 patients underwent uncomplicated coronary artery bypass grafting after preoperative treatment with intravenous immunoglobulin and intraoperative platelet transfusions if needed. Prophylactic splenectomy was not performed. There was no increased incidence of bleeding complications.
CONCLUSIONS: Coronary artery bypass grafting can be safely performed in patients with idiopathic thrombocytopenic purpura using conventional conduits after pretreating with immunoglobulin G and avoiding splenectomy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354527     DOI: 10.1016/s0003-4975(97)00763-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Aortic valve replacement in a patient with idiopathic thrombocytopenic purpura.

Authors:  T Kumamoto; S Higashi; T Sumida
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-04

Review 2.  Retention of atherogenic lipoproteins in atherogenesis.

Authors:  M Gustafsson; C Flood; P Jirholt; J Borén
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

3.  Endobronchial hemorrhage after intubation with double-lumen endotracheal tube in a patient with idiopathic thrombocytopenic purpura for minimally invasive cardiac surgery: a case report.

Authors:  Hee Young Kim; Seung Hoon Baek; Kyoung Hoon Kim; Nam Won Kim
Journal:  Korean J Anesthesiol       Date:  2014-01-28

Review 4.  Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.

Authors:  Aleksandar N Neskovic; Ivan Stankovic; Predrag Milicevic; Aleksandar Aleksic; Alja Vlahovic-Stipac; Branko Calija; Biljana Putnikovic
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

5.  Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.

Authors:  Syed Wamique Yusuf; Cezar Iliescu; Jaya D Bathina; Iyad N Daher; Jean-Bernard Durand
Journal:  Tex Heart Inst J       Date:  2010

6.  Coronary artery bypass grafting in idiopathic thrombocytopenia: use of thromboelastometry without platelet transfusion.

Authors:  Michele Rossi; Michael Lewis; Nevil Hutchinson
Journal:  Tex Heart Inst J       Date:  2010

Review 7.  Mitral valve replacement in a patient with idiopathic thrombocytopenic purpura.

Authors:  J Oba; H Aoki; T Yoshida; T Kanaoka; K Oe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-02

8.  Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease.

Authors:  Chan-Hee Lee; Ung Kim
Journal:  Korean Circ J       Date:  2014-07-25       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.